US BANCORP \DE\ - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$211,442
-24.8%
6,687
-3.1%
0.00%
Q2 2023$281,342
+7.1%
6,899
-2.1%
0.00%
Q1 2023$262,754
+16.5%
7,050
+9.0%
0.00%
Q4 2022$225,564
-66.5%
6,465
-46.3%
0.00%
-100.0%
Q3 2022$673,000
+49.9%
12,040
+38.5%
0.00%0.0%
Q2 2022$449,000
-59.3%
8,695
-42.8%
0.00%
-50.0%
Q1 2022$1,104,000
-36.3%
15,203
+3.8%
0.00%
-33.3%
Q4 2021$1,732,000
+0.5%
14,645
+14.0%
0.00%0.0%
Q3 2021$1,723,000
-6.7%
12,845
+12.7%
0.00%0.0%
Q2 2021$1,846,000
+281.4%
11,401
+89.2%
0.00%
+200.0%
Q1 2021$484,000
+1208.1%
6,026
+792.7%
0.00%
Q4 2020$37,000
-37.3%
675
-77.3%
0.00%
Q3 2020$59,000
-48.7%
2,975
-45.7%
0.00%
Q2 2020$115,000
+173.8%
5,475
+57.6%
0.00%
Q1 2020$42,000
+1300.0%
3,475
+1885.7%
0.00%
Q4 2019$3,000
+50.0%
1750.0%0.00%
Q3 2019$2,000
-33.3%
1750.0%0.00%
Q2 2019$3,0000.0%1750.0%0.00%
Q1 2019$3,000
+50.0%
1750.0%0.00%
Q4 2018$2,000
-60.0%
1750.0%0.00%
Q3 2018$5,0001750.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders